Glycosmedia

Diabetes News Service

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Diabetes News

Category: Monitoring


Low serum apelin levels are associated with mild cognitive impairment in Type 2 diabetic patients

May 25th 2022

Serum apelin level is reduced in T2DM patients with MCI. Apelin might has protective effect against cognitive impairment and serve as a serum biomarker of T2DM (BMC Endocrine Disorders)

Categories: Monitoring, News, Psychological
Tags: apelin, cognitive impairment, Type 2 Diabetes

Categories: Monitoring, Psychological
Tags: apelin, cognitive impairment, Type 2 Diabetes

Variability in Test Interval Is Linked to Glycated Haemoglobin (HbA1c) Trajectory over Time

May 16th 2022

These findings indicate that the consistency of testing interval, not the just number of tests/year, is important in maintaining diabetes control, especially in those with moderately raised HbA1c levels (Journal of Diabetes Research)

Categories: Monitoring, News
Tags: HbA1c

Categories: Monitoring
Tags: HbA1c

Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes

May 12th 2022

isCGM use provided an initial improvement in glycaemic control that was not sustained. Furthermore, offspring of isCGM users were more likely to have neonatal hypoglycaemia, with similar rates of macrosomia and prematurity to those of women receiving standard care (Diabetologia)

Categories: Gestational, Monitoring, News
Tags: CGM, Type 1 Diabetes

Categories: Gestational, Monitoring
Tags: CGM, Type 1 Diabetes

Acute glycemic variability and mortality of patients with acute stroke: a meta-analysis

May 11th 2022

Higher acute GV may be an independent risk factor of early mortality in patients with acute stroke (Diabetology & Metabolic Syndrome)

Categories: Cardiovascular, Monitoring, News
Tags: glycemic variability, stroke

Categories: Cardiovascular, Monitoring
Tags: glycemic variability, stroke

Is HbA1c a valid surrogate for mortality in type 2 diabetes? Evidence from a meta-analysis of randomized trials

May 10th 2022

Based on the results of more than 200 randomized trials, HbA1c is not a valid surrogate marker for all-cause mortality in people with type 2 diabetes (Acta Diabetologica)

Categories: Monitoring, News
Tags: HbA1c, mortality, Type 2 Diabetes

Categories: Monitoring
Tags: HbA1c, mortality, Type 2 Diabetes

Differential prognostic burden of cardiovascular disease and lower-limb amputation on the risk of all-cause death in people with long-standing type 1 diabetes

May 10th 2022

CVD and LLA conferred a similar burden regarding mortality in type 1 diabetes population. Our findings encourage a careful consideration of people with type 1 diabetes and LLA as usually recommended for those with CVD, in terms of management of risk factors, treatments and prevention (Cardiovascular Diabetology)

Categories: Cardiovascular, Monitoring, News
Tags: amputation, mortality, Type 1 Diabetes

Categories: Cardiovascular, Monitoring
Tags: amputation, mortality, Type 1 Diabetes

Prognostic significance of metabolomic biomarkers in patients with diabetes mellitus and coronary artery disease

May 8th 2022

In patients with comorbid DM and CAD, novel metabolomic biomarkers and metabolomics-based prediction models could be recruited to predict clinical outcomes and assess the complexity of CAD, thereby enabling the integration of personalized medicine into routine clinical practice (Cardiovascular Diabetology)

Categories: Cardiovascular, Monitoring, News
Tags: biomarkers, metabolomic

Categories: Cardiovascular, Monitoring
Tags: biomarkers, metabolomic

Reductions in HbA1c with Flash Glucose Monitoring Are Sustained for up to 24 Months: A Meta-Analysis of 75 Real-World Observational Studies

April 27th 2022

Meta-analysis of RWE confirms that using the FreeStyle Libre system is associated with significant reductions in HbA1c for adults with T1DM or with T2DM. Reductions are greater for people with higher baseline HbA1c and are sustained for 24 and 12 months in T1DM and TD2M respectively (Diabetes Therapy)

Categories: Monitoring, News
Tags: FreeStyle, HbA1c, Type 1 Diabetes, Type 2 Diabetes

Categories: Monitoring
Tags: FreeStyle, HbA1c, Type 1 Diabetes, Type 2 Diabetes

Type 2 diabetes classification: a data-driven cluster study of the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) cohort

April 18th 2022

Different HOMA2-based approaches did not classify patients with T2D in a consistent manner. The T2D classes characterized by high insulin resistance/hyperinsulinemia appeared most distinct (BMJ Open, Diabetes Research & Care)

Categories: Genetics, Monitoring, News
Tags: hyperinsulinemia, Insulin resistance, Type 2 Diabetes

Categories: Genetics, Monitoring
Tags: hyperinsulinemia, Insulin resistance, Type 2 Diabetes

Coordination of glucose monitoring, self-care behaviour and mental health: achieving precision monitoring in diabetes

April 6th 2022

Micro-interventions are responsive to real-life circumstances and are adaptive to the specific needs of an individual with diabetes. We conclude that, with current developments in big data analysis, there is a huge potential for precision monitoring in diabetes (Diabetologia)

Categories: Management, Monitoring, News, Psychological
Tags: self-care

Categories: Management, Monitoring, Psychological
Tags: self-care

Metformin and high-sensitivity cardiac troponin I and T trajectories in type 2 diabetes patients: a post-hoc analysis of a randomized controlled trial

April 5th 2022

In this post-hoc analysis of a 4.3-year randomized controlled trial, metformin did not exert a clinically relevant effect on cardiac troponin I and cardiac troponin T levels when compared to placebo. Cardioprotective effects of the drug observed in clinical studies are not reflected by a reduction in these biomarkers of subclinical myocardial injury (Cardiovascular Diabetology)

Categories: Monitoring, News, Pathology
Tags: cardiac troponin, Type 2 Diabetes

Categories: Monitoring, Pathology
Tags: cardiac troponin, Type 2 Diabetes

Modeling Chronic Kidney Disease in Type 2 Diabetes Mellitus: A Systematic Literature Review of Models, Data Sources, and Derivation Cohorts

March 16th 2022

Modeling CKD in T2DM is an active research area, with a trend towards IPS models developed from non-Western data and single data sources, primarily recent outcomes trials of novel renoprotective treatments (Diabetes Therapy)

Categories: Monitoring, Nephropathy, News
Tags: CKD, Type 2 Diabetes

Categories: Monitoring, Nephropathy
Tags: CKD, Type 2 Diabetes

Ambulatory Glucose Profile (AGP) Report in Daily Care of Patients with Diabetes: Practical Tips and Recommendations

March 13th 2022

Report and illustrate the essential components of an AGP review in a series of hypothetical, real-world, patient-centred case studies (Diabetes Therapy)

Categories: Monitoring, News, Screening

Categories: Monitoring, Screening

Serum bile acid response to oral glucose is attenuated in patients with early type 2 diabetes and correlates with 2h plasma glucose in individuals without diabetes

March 4th 2022

The serum BA response to a 75g oral glucose load is attenuated in patients with ‘early’ T2D, as is the secretion of FGF-19 and GLP-1, while in individuals without T2D it correlates with 2h plasma glucose levels. These observations support a role for BAs in the regulation of postprandial glucose metabolism (Diabetes, Obesity and Metabolism)

Categories: Monitoring, News
Tags: bile acids, Type 2 Diabetes

Categories: Monitoring
Tags: bile acids, Type 2 Diabetes

HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target

January 27th 2022

These findings suggest that HbA1c variability may provide additional information for an optimized management of diabetes, particularly in people within the target of HbA1c (Cardiovascular Diabetology)

Categories: Cardiovascular, Management, Monitoring, News
Tags: HbA1c, Type 2 Diabetes

Categories: Cardiovascular, Management, Monitoring
Tags: HbA1c, Type 2 Diabetes

Continuous Glucose Monitoring in Adults With Type 1 Diabetes With 35 Years Duration From the DCCT/EDIC Study

January 26th 2022

The small subset of participants using routine CGM and insulin pumps had fewer hypoglycemic and hyperglycemic excursions and lower HbA1c levels. Thus, strategies to lower meal-stimulated hyperglycemia during the day and prevent hypoglycemia at night are relevant clinical goals in older patients with type 1 diabetes (Diabetes Care)

Categories: Monitoring, News
Tags: CGM, hyperglycemia, hypoglycemia, insulin pump, Type 1 Diabetes

Categories: Monitoring
Tags: CGM, hyperglycemia, hypoglycemia, insulin pump, Type 1 Diabetes

Characterising the age-dependent effects of risk factors on type 1 diabetes progression

January 19th 2022

Analysing the age-varying effect of disease predictors improves understanding and prediction of type 1 diabetes disease progression, and should be leveraged to refine prediction models and guide mechanistic studies (Diabetologia)

Categories: Monitoring, News, Screening
Tags: Type 1 Diabetes

Categories: Monitoring, Screening
Tags: Type 1 Diabetes

The Association of Postprandial Triglyceride Variability with Renal Dysfunction and Microalbuminuria in Patients with Type 2 Diabetic Mellitus

January 10th 2022

Postprandial TG variability is a novel risk factor for eGFR decline and the incidence of microalbuminuria in patients with type 2 DM (Journal of Diabetes Research)

Categories: Monitoring, Nephropathy, News
Tags: microalbuminuria, triglyceride, Type 2 Diabetes

Categories: Monitoring, Nephropathy
Tags: microalbuminuria, triglyceride, Type 2 Diabetes

Relationship between glycosylated hemoglobin and iron deficiency anemia: A common but overlooked problem

January 7th 2022

Our study has shown conclusivly that IDA is related to increased HbA1c concentrations and HbA1c decreases significantly following treatment with iron. IDA should be considered before making any decisions regarding diagnosis or treatment according to HbA1c (Primary Care Diabetes)

Categories: Monitoring, News
Tags: anemia, HbA1c

Categories: Monitoring
Tags: anemia, HbA1c

Use of Real-Time Continuous Glucose Monitoring Improves Glycemic Control and Other Clinical Outcomes in Type 2 Diabetes Patients Treated with Less Intensive Therapy

January 7th 2022

rtCGM use was associated with significant glycemic improvements in T2D patients treated with basal insulin only or noninsulin therapy. Given the growing body of evidence supporting rtCGM use in this population, insurance eligibility criteria should be modified to expand rtCGM use by T2D patients treated with less intensive therapies (Diabetes Technology and Therapeutics)

Categories: Monitoring, News, Treatment
Tags: rtCGM, Type 2 Diabetes

Categories: Monitoring, Treatment
Tags: rtCGM, Type 2 Diabetes
  • 1
  • 2
  • 3
  • …
  • 15
  • Next Page »

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Gold Sponsors

Boehringer IngelheimNovo NordiskAstraZenecaNapp Diabetes

Silver Sponsors

Welsh Endocrinology and Diabetes Society (WEDS)About Ascensia Diabetes CareAbbott Diabetes Care

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Categories

  • Audits
  • Bariatric
  • Biochemistry
  • Cardiovascular
  • Devices
  • Diagnosis
  • Diet
  • Education
  • Epidemiology
  • Genetics
  • Gestational
  • Guidance
  • Guidelines
  • Hepatology
  • Hypertension
  • Immunology
  • Management
  • Media
  • Medication
  • Meetings
  • Monitoring
  • Nephrology
  • Neuropathy
  • Nephropathy
  • Obesity
  • Ophthalmology
  • Paediatrics
  • Pathology
  • Pharma
  • Pharmacology
  • Physiology
  • Podiatry
  • Prediabetes
  • Prevalence
  • Prevention
  • Psychological
  • Reports
  • Research
  • Screening
  • Sponsorship
  • Technology
  • Testing
  • Transplantation
  • Treatment
  • Wound Care

To see all articles associated with a category just click on the category name.

Popular Tags

ADA BMI canagliflozin CGM CKD closed-loop COVID-19 dapagliflozin DPP4 DPP4 inhibitors elderly Empagliflozin exenatide GLP-1 RA GLP-1RA GLP1 glycaemic control HbA1c heart failure hyperglycemia hypoglycemia incretin insulin insulin pump Insulin resistance Ketoacidosis liraglutide metformin mortality NICE pioglitazone retinopathy semaglutide SGLT2 inhibitors sitagliptin statin sulfonylureas Type 1 Diabetes Type 2 Diabetes Vitamin D

To see all articles associated with a tag just click on the tag name.

Complete list of Tags ››

Join us on Facebook

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

My Tweets

mobileGlycosmedia is also available as an App:

For iPhone and iPad | For Android devices


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Copyright © 2022 Glycosmedia Partnership